Quick Takeaways
- Laurence W. Lytton filed SCHEDULE 13G/A for Cellectar Biosciences, Inc. Common Stock (CLRB).
- Disclosed ownership: 8.8%.
- Date of event: 31 Dec 2024.
Laurence W. Lytton - 31 Dec 2024 SCHEDULE 13G/A Report for Cellectar Biosciences, Inc. Common Stock (CLRB)
- Filing Manager
- Laurence W. Lytton
- Reporting Manager
- LYTTON LAURENCE W
- Symbol
- CLRB
- Shares outstanding
- 44,948,523 shares
- Disclosed Ownership
- 3,955,470 shares
- Ownership
- 8.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2025, 15:49:47 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Laurence W. Lytton disclosed 8.8% ownership in Cellectar Biosciences, Inc. Common Stock (CLRB) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 15:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 8.8% | 3,955,470 | 3,955,470 | 0 | /s/ Laurence W. Lytton | Reporting person |